@Bullrush007 In the scheme of things...a 5 day trial with 30 covid19 subjects is very achievable and not very expensive compared to other trials.
The world has Delta and Omicron variants and they are infecting Double vaccinated.
There is direction from Joe Biden to the FDA to accelerate the approval process and they already have a fasttrack process.
Biotron is within those crosshairs.
BIt225 has shown immune restoration capabilities.
BIt225 may be approved just for immune restoration properties.
There is a clear path for Biotron according to US Professor Murphy.
